A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy

Acta Derm Venereol. 2002;82(5):382-4. doi: 10.1080/000155502320624177.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Autoantibodies / analysis*
  • Autoantigens / analysis*
  • Azathioprine / administration & dosage
  • Cytoskeletal Proteins / analysis
  • Cytoskeletal Proteins / immunology
  • Desmoplakins
  • Disease Progression
  • Drug Therapy, Combination
  • Fatal Outcome
  • Fluorescent Antibody Technique, Direct
  • Humans
  • Intermediate Filament Proteins / analysis
  • Intermediate Filament Proteins / immunology
  • Male
  • Paraneoplastic Syndromes / diagnosis*
  • Paraneoplastic Syndromes / drug therapy
  • Paraneoplastic Syndromes / immunology*
  • Pemphigus / diagnosis*
  • Pemphigus / drug therapy
  • Pemphigus / immunology*
  • Plectin
  • Prednisone / administration & dosage
  • Risk Assessment

Substances

  • Autoantibodies
  • Autoantigens
  • Cytoskeletal Proteins
  • Desmoplakins
  • Intermediate Filament Proteins
  • PLEC protein, human
  • Plectin
  • Azathioprine
  • Prednisone